Our Mission: to transform the experience of finding, participating in, and conducting clinical trials.
Circuit Clinical® was founded to make it easier for people to find, understand, and choose clinical research as a care option for themselves and their loved ones.
Clinical trials require large numbers of patients who are affected by a condition and who also fall within a very specific set of criteria.
Connecting the right patient with the right trial is an extremely daunting process and many patients who could qualify for trials never even find out
about them as a care option. For example, nearly 40% of oncology clinical trials never recruit the targeted number of patients.
This extends the time it takes to bring new medicines to market and also significantly drives up the cost of drug development. Worst of all, it can prevent drugs and devices from ever making it to the market at all.
There are barriers for doctors to participate in research as well. Doctors in private practice, for example, often do not have the support staff or experience they need to deal with the regulatory paperwork, legal compliance, and day-to-day management required for their patients to participate in a clinical trial.
“With a hardworking team, an innovative product, and the right market, startups can succeed here…It is with the support of our community, our advisors, our team, and the people who believe in us that has got us to where we are today and where we’ll go in the future.”
In 2016, Dr. Khan made the decision to leave medical practice to bring private practices, hospitals,
and health systems together with Circuit’s turnkey research team to deliver research as a care option.
Our core belief is that patients prefer to learn about clinical research from healthcare providers they already know and trust. That’s why our team is integrated within our network to deliver clinical research where it matters most to patients – their own doctors’ offices.
Since then, we have created a network of 90+ investigators across the US, and a nationally accredited cancer center with a database of more than 2.5 million patients who may qualify for clinical trials. So far, we have played a significant role in studies spanning ten therapeutic areas, including cardiovascular disease, diabetes, women’s health, kidney disease, digestive diseases, rheumatoid arthritis, cancer, COVID-19, and others.
We won Buffalo's 43North Competition
We form a strategic partnership with Labcorp
TrialScout gets rebranded into TrialJourney
We partner with Medidata to offer a turnkey DCT solution
Closed $29M Series C
Members on the team
Clinical projects completed
Raised in Series C backed by Labcorp and Medidata
Inc. Magazine Best Workplaces
Fast Company World Changing Ideas Award
Buffalo Business First Best Places to Work